QNRX Stock Summary and Trading Ideas (Quoin Pharmaceuticals Ltd. - American Depositary Shares | NASDAQ:QNRX)

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Quoin Pharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol QNRX.

As of July 10, 2026, QNRX stock price declined to $4.32 with 16,115 million shares trading.

QNRX has a beta of -1.09, meaning it tends to be less sensitive to market movements. QNRX has a correlation of 0.01 to the broad based SPY ETF.

QNRX has a market cap of $8.68 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNRX traded as high as $420.00 and as low as $3.25.

QNRX has underperformed the market in the last year with a return of -53.8%, while the SPY ETF gained +22.1%. In the last 3 month period, QNRX fell short of the market, returning -24.7%, while SPY returned +11.3%. However, in the most recent 2 weeks QNRX has outperformed the stock market by returning +2.9%, while SPY returned +2.8%.

QNRX support price is $4.24 and resistance is $5.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNRX shares will trade within this expected range on the day.